EDWARDS LIFESCIENCES CORP
EDWARDS LIFESCIENCES CORP/ US28176E1082 /
EWLS
06.09.2024 17:32:11
|
Zm.
-0,55
|
Wolumen |
Bid17:32:11 |
Ask17:32:11 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
59,58EUR
|
-0,91%
|
0 Obrót: - |
-Wolumen Bid: - |
-Wolumen Ask: - |
36,3 mldEUR |
- |
- |
Opis działalności
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Zarząd & Rada nadzorcza
CEO |
Bernard J. Zovighian |
Zarząd |
Scott B. Ullem, Donald E. Bobo Jr., Todd J. Brinton, Daveen Chopra, Dirksen J. Lehman, Jean-Luc Lemercier, Wayne Markowitz, Christine Z. McCauley, Joseph Nuzzolese |
Rada nadzorcza |
Michael A. Mussallem, Kieran T. Gallahue, Leslie S. Heisz, Martha H. Marsh, Nicholas J. Valeriani, Paul A. LaViolette, Ramona Sequeira, Steven R. Loranger, Bernard J. Zovighan |
Dane firmy
Nazwa: |
Edwards Lifesciences Corp. |
Adres: |
One Edwards Way,Irvine, California 92614, USA |
Telefon: |
+1-949-250-2500 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.edwards.com/ |
Przemysł: |
Biotechnologia |
Sektor: |
Biotechnologia |
Podsektor: |
Biotechnologia |
Koniec roku finansowego: |
31.12 |
Free float: |
83,04% |
Data IPO: |
03.04.2000 |
Główni akcjonariusze
Inne |
|
61,33% |
Vanguard Group |
|
8,68% |
BlackRock Inc. |
|
8,65% |
State Street Corporation |
|
4,47% |
ALLIANCEBERNSTEIN L P |
|
3,16% |
BROWN ADVISORY INC |
|
3,01% |
The Bank of New York Mellon Corp. |
|
2,87% |
Wellington Management Group |
|
2,79% |
GEODE CAPITAL MANAGEMENT LLC |
|
2,13% |
Inne |
|
2,91% |